Bone Therapeutics SA Stock Euronext Bruxelles
Equities
BOTHE
BE0974280126
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 3.07M 3.33M 0 |
---|---|---|---|---|---|
Net income 2023 * | -5M -5.43M - | Net income 2024 * | -11M -11.94M - | EV / Sales 2023 * | - |
Net Debt 2023 * | 18.8M 20.41M 0 | Net Debt 2024 * | 29.3M 31.81M 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.29
x | P/E ratio 2024 * |
-0.16
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.65% |
Managers | Title | Age | Since |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-02 |
Nicco Carole
COO | Chief Operating Officer | - | 23-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- BIOS Stock
- BOTHE Stock